LRMR — Larimar Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual balance sheet for Larimar Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	70.3	92.6	70.1	118	86.8
Net Total Receivables	0.243	—	0.208	0	—
Prepaid Expenses
Total Current Assets	71.5	98	72.2	121	90.2
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	7.87	4.98	4.46	3.69	3.76
Other Long Term Assets
Total Assets	80.7	105	78.7	126	95.9
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	12.2	8.99	8.85	10.7	9.51
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	27.1	15	14.3	15.5	14.2
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	53.6	89.7	64.4	111	81.7
Total Liabilities & Shareholders' Equity	80.7	105	78.7	126	95.9
Total Common Shares Outstanding